Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF274 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | PSG4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | NCAPG2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | CD3E | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | TRO | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | ATG4C | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | AUTS2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | DCAF4L1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | RP11-96O20.4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | RNF38 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |